Jonathan J. Juliano

Jonathan J Juliano is an American physician/scientist. He currently works at UNC (University of North Carolina).

Biography

Jonathan Juliano is an Assistant Professor in the Department of Medicine at the University of North Carolina at Chapel Hill. He has been on faculty since 2009. In addition, he is an adjunct assistant professor in the Department of Epidemiology at the Gillings School of Global Public Health and an instructor in the Curriculum of Genetics and Molecular Biology. He received his BSc from University of Toronto, Toronto, Canada in 1994 with Distinction. He completed a MSPH at the UNC School of Public Health and his MD at the UNC School of Medicine in 2001. He trained in Internal Medicine and Pediatrics at the University of Minnesota, Minneapolis, MN from 2001 to 2005. Following this, he completed his Infectious Disease Fellowship at University of North Carolina, Chapel Hill, NC in 2008. He is board certified in Internal Medicine and Infectious Diseases.

Research

Jonathan Juliano has led research efforts in infectious diseases and genetics, with the goal of improving our understanding of how infections cause disease, how infectious agents evolve, and how the genetic diversity impacts our understanding of drug resistance. His work has focused on malaria; however he has worked with other agents as well.[1][2] In particular, he is interested in understanding within host genetic diversity of malaria infections, as each infection may contain multiple genetically different parasite strains, and the impact of this diversity on drug and vaccine efficacy.[3][4] His work in this area has called into question some of the current practices of how clinical trials for malaria are conducted.[5][6][7][8] He has been the recipient of several awards including the Merle A. Sande/Pfizer Fellowship Award in International Diseases and the Terry Lee Award from the North Carolina Infectious Disease Society.[9] He has also authored articles and a book chapter concerning the clinical care of malaria.[10][11] Dr. Jonathan Juliano collaborates with Dr. Carla Cerami at the University of North Carolina and with Dr. Steve M. Taylor at Duke University School of Medicine.[12]

References

  1. ↑ Carter, YL; Juliano, JJ; Montgomery, SP; Qvarnstrom, Y (2012). "Acute chagas disease in a returning traveler". The American journal of tropical medicine and hygiene 87 (6): 1038–40. doi:10.4269/ajtmh.2012.12-0354. PMID 23091192.
  2. ↑ Bratton, EW; El Husseini, N; Chastain, CA; Lee, MS; Poole, C; Stürmer, T; Juliano, JJ; Weber, DJ; Perfect, JR (2012). "Correction: Comparison and Temporal Trends of Three Groups with Cryptococcosis: HIV-Infected, Solid Organ Transplant, and HIV-Negative/Non-Transplant". PLOS ONE 7 (10). doi:10.1371/annotation/a94bc542-6682-4579-a315-57019cef7e0e. PMC 3507528.
  3. ↑ Juliano, JJ; Porter, K; Mwapasa, V; Sem, R; Rogers, WO; Ariey, F; Wongsrichanalai, C; Read, A; Meshnick, SR (2010). "Exposing malaria in-host diversity and estimating population diversity by capture-recapture using massively parallel pyrosequencing". Proceedings of the National Academy of Sciences of the United States of America 107 (46): 20138–43. doi:10.1073/pnas.1007068107. PMC 2993407. PMID 21041629.
  4. ↑ Bailey, JA; Mvalo, T; Aragam, N; Weiser, M; Congdon, S; Kamwendo, D; Martinson, F; Hoffman, I; Meshnick, SR; Juliano, JJ (2012). "Use of massively parallel pyrosequencing to evaluate the diversity of and selection on Plasmodium falciparum csp T-cell epitopes in Lilongwe, Malawi". The Journal of Infectious Diseases 206 (4): 580–7. doi:10.1093/infdis/jis329. PMC 3491736. PMID 22551816.
  5. ↑ Juliano, JJ; Taylor, SM; Meshnick, SR (2009). "Polymerase chain reaction adjustment in antimalarial trials: Molecular malarkey?". The Journal of Infectious Diseases 200 (1): 5–7. doi:10.1086/599379. PMC 2803033. PMID 19469704.
  6. ↑ Juliano, JJ; Ariey, F; Sem, R; Tangpukdee, N; Krudsood, S; Olson, C; Looareesuwan, S; Rogers, WO; Wongsrichanalai, C; Meshnick, SR (2009). "Misclassification of drug failure in Plasmodium falciparum clinical trials in southeast Asia". The Journal of Infectious Diseases 200 (4): 624–8. doi:10.1086/600892. PMC 2761972. PMID 19591576.
  7. ↑ Juliano, JJ; Gadalla, N; Sutherland, CJ; Meshnick, SR (2010). "The perils of PCR: Can we accurately 'correct' antimalarial trials?". Trends in parasitology 26 (3): 119–24. doi:10.1016/j.pt.2009.12.007. PMC 2844636. PMID 20083436.
  8. ↑ Porter, KA; Burch, CL; Poole, C; Juliano, JJ; Cole, SR; Meshnick, SR (2011). "Uncertain outcomes: Adjusting for misclassification in antimalarial efficacy studies". Epidemiology and infection 139 (4): 544–51. doi:10.1017/S0950268810001652. PMID 20619072.
  9. ↑ Merle Sande: http://www.idsociety.org/Merle_A._Sande_Pfizer_Fellowship_Award/[]
  10. ↑ Taylor, SM; Molyneux, ME; Simel, DL; Meshnick, SR; Juliano, JJ (2010). "Does this patient have malaria?". JAMA: the Journal of the American Medical Association 304 (18): 2048–56. doi:10.1001/jama.2010.1578. PMID 21057136.
  11. ↑ Book chapter: Netter’s Internal medicine, 2e. Saunders. ISBN 978-1416044178
  12. ↑ Taylor, S. M.; Messina, J. P.; Hand, C. C.; Juliano, J. J.; Muwonga, J.; Tshefu, A. K.; Atua, B.; Emch, M.; Meshnick, S. R. (2011). Braga, Erika Martins, ed. "Molecular Malaria Epidemiology: Mapping and Burden Estimates for the Democratic Republic of the Congo, 2007". PLOS ONE 6 (1): e16420. doi:10.1371/journal.pone.0016420. PMC 3031549. PMID 21305011.

External links

This article is issued from Wikipedia - version of the Saturday, April 30, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.